Oramed Pharmaceuticals, Inc. (ORMP)
4.74
-0.05
(-1.04%)
USD |
NASDAQ |
Sep 25, 16:00
4.74
0.00 (0.00%)
After-Hours: 19:59
Oramed Pharmaceuticals Research and Development Expense (Annual) : 6.381M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 6.381M |
| December 31, 2024 | 6.324M |
| December 31, 2023 | 8.775M |
| December 31, 2022 | 27.58M |
| August 31, 2021 | 19.87M |
| August 31, 2020 | 10.23M |
| August 31, 2019 | 13.52M |
| August 31, 2018 | 11.98M |
| August 31, 2017 | 10.28M |
| August 31, 2016 | 7.709M |
| August 31, 2015 | 4.83M |
| Date | Value |
|---|---|
| August 31, 2014 | 3.705M |
| August 31, 2013 | 2.272M |
| August 31, 2012 | 1.681M |
| August 31, 2011 | 1.131M |
| August 31, 2010 | 1.464M |
| August 31, 2009 | 1.522M |
| August 31, 2008 | 1.176M |
| August 31, 2007 | 2.214M |
| August 31, 2006 | 0.1977M |
| August 31, 2005 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |
| Liquidia Corp. | 38.45M |
| Scilex Holding Co. | 20.71M |
| BioAge Labs, Inc. | 73.97M |